These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24468896)

  • 1. Risk factors for clinical events at 1-year follow-up after drug-eluting stent implantation: results from the prospective multicenter German DES.DE registry.
    Akin I; Nienaber CA; Richardt G; Tölg R; Hochadel M; Schneider S; Senges J; Tebbe U; Zeymer U; Sabin G; Kuck KH; Bergmann MW
    Clin Res Cardiol; 2014 May; 103(5):363-72. PubMed ID: 24468896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes with Biolimus (A9)™ eluting stent, 'BioMatrix' in diabetic patients--interim results from multicenter post market surveillance registry in India.
    Seth A; Hiremath S; Dani S; Kapoor S; Jain RK; Abhaichand R; Trivedi S; Kaul U; Patil A; Khemnar B; Rangnekar H
    Indian Heart J; 2013; 65(5):586-92. PubMed ID: 24206882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
    EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes after differential use of drug-eluting stents in diabetic patients: 1-year results from the DES.DE (Drug-Eluting Stent.DEutschland) registry.
    Akin I; Bufe A; Eckardt L; Reinecke H; Richardt G; Kuck KH; Senges J; Schneider S; Nienaber CA;
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):50-7. PubMed ID: 20578192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of different first- and second-generation drug-eluting stents in routine clinical practice: results from the prospective multicenter German DES.DE registry.
    Akin I; Hochadel M; Abdel-Wahab M; Senges J; Richardt G; Schneider S; Tebbe U; Kuck KH; Nienaber CA
    Clin Res Cardiol; 2013 May; 102(5):371-81. PubMed ID: 23386256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of percutaneous coronary intervention with drug-eluting stents in unprotected left main versus non-left main native coronary artery disease: results from the prospective multicenter German DES.DE registry.
    Akin I; Naber C; Sabin G; Hochadel M; Senges J; Kuck KH; Nienaber C; Richardt G; Tölg R
    Clin Res Cardiol; 2013 Sep; 102(9):679-86. PubMed ID: 23681360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of smoking on the outcome of patients treated with drug-eluting stents: 1-year results from the prospective multicentre German Drug-Eluting Stent Registry (DES.DE).
    Sherif MA; Nienaber CA; Toelg R; Abdel-Wahab M; Geist V; Schneider S; Senges J; Kuck KH; Tebbe U; Richardt G
    Clin Res Cardiol; 2011 May; 100(5):413-23. PubMed ID: 21116637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-year clinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent: final results of the intracoronary stenting and angiographic restenosis - test equivalence between two drug-eluting stents (ISAR-TEST) trial.
    King L; Byrne RA; Mehilli J; Schömig A; Kastrati A; Pache J
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):E23-8. PubMed ID: 22431239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry.
    Akin I; Tölg R; Hochadel M; Bergmann MW; Khattab AA; Schneider S; Senges J; Kuck KH; Richardt G; Nienaber CA;
    JACC Cardiovasc Interv; 2012 Feb; 5(2):162-9. PubMed ID: 22361600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of drug-eluting stents in acute myocardial infarction with persistent ST-segment elevation: results of the ALKK PCI-registry.
    Härle T; Zeymer U; Schwarz AK; Lüers C; Hochadel M; Darius H; Kasper W; Hauptmann KE; Andresen D; Elsässer A
    Clin Res Cardiol; 2014 May; 103(5):373-80. PubMed ID: 24435358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.
    Wiemer M; Serruys PW; Miquel-Hebert K; Neumann FJ; Piek JJ; Grube E; Haase J; Thuesen L; Hamm C
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):997-1003. PubMed ID: 20517959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative assessment of mammalian target of rapamycin inhibitor-eluting stents in the treatment of coronary artery bifurcation lesions: the CASTOR-Bifurcation registry.
    Sgueglia GA; Burzotta F; Trani C; Todaro D; Talarico GP; Niccoli G; Porto I; Leone AM; Coluccia V; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):503-9. PubMed ID: 20602477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of early versus late clopidogrel discontinuation on stent thrombosis following percutaneous coronary intervention with first- and second-generation drug-eluting stents.
    Loh JP; Torguson R; Pendyala LK; Omar A; Chen F; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2014 Jun; 113(12):1968-76. PubMed ID: 24767975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry.
    Auffret V; Berland J; Barragan P; Waliszewski M; Bonello L; Delarche N; Furber A; Albert F; Carrié D; Eltchaninoff H; Pansieri M; Schneeberger M; Piot C; Marcollet P; Bedossa M
    Int J Cardiol; 2016 Jan; 203():690-6. PubMed ID: 26583844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug eluting stenting in bifurcation coronary lesions long-term results applying a systematic treatment strategy.
    Assali AR; Vaknin-Assa H; Lev E; Teplitsky I; Dvir D; Brosh D; Bental T; Battler A; Kornowski R
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):615-22. PubMed ID: 22162218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical results and predictors of adverse outcomes after drug-eluting stent implantation for bifurcation lesions in a real-world practice: the COBIS (Coronary Bifurcation Stenting) registry.
    Gwon HC; Choi SH; Song YB; Hahn JY; Jeong MH; Seong IW; Kim HS; Rha SW; Yang JY; Yoon JH; Tahk SJ; Seung KB; Jang Y; Park SJ
    Circ J; 2010 Nov; 74(11):2322-8. PubMed ID: 20890049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
    Byrne RA; Kastrati A; Tiroch K; Schulz S; Pache J; Pinieck S; Massberg S; Seyfarth M; Laugwitz KL; Birkmeier KA; Schömig A; Mehilli J;
    J Am Coll Cardiol; 2010 Jun; 55(23):2536-43. PubMed ID: 20417052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome after drug-eluting stent implantation in unselected population: ROME and UDINE experience (the RUDI registry).
    Sardella G; Conti G; Bisceglia T; Canali E; Mancone M; De Carlo C; Spedicato L; Morocutti G; Fedele F; Bernardi G
    Catheter Cardiovasc Interv; 2011 Dec; 78(7):1068-75. PubMed ID: 21567883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA Trial (Xience or Vision Stents for the Management of Angina in the Elderly).
    de Belder A; de la Torre Hernandez JM; Lopez-Palop R; O'Kane P; Hernandez Hernandez F; Strange J; Gimeno F; Cotton J; Diaz Fernandez JF; Carrillo Saez P; Thomas M; Pinar E; Curzen N; Baz JA; Cooter N; Lozano I; Skipper N; Robinson D; Hildick-Smith D;
    J Am Coll Cardiol; 2014 Apr; 63(14):1371-5. PubMed ID: 24216285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.